bond interaction and extended conjugation. Both the 1H NMR and 13C NMR data were in good agreement with
the results reported for the reference compound 1,1-diphenyl-3-(2-phenyl-3H-quinazolin-4-ylidene)thiourea [12]
prepared by the reaction of diphenylamine and imidoyl isothiocyanate. The 13C NMR spectrum of
thiosemicarbazide 6 gave signals at 181.91, 155.85, 149.34, 67.45, 55.52, 27.96, and 17.05 ppm assigned to
C=S, C-2, C-4, C=CH2, C=CH2, CH2=CCH3, and CH3, respectively, which gave clear evidence for the
participation of two acetone molecules in the reaction.
Thus, the reaction of N-(2-cyanophenyl)benzimidoyl isothiocyanate 1 with hydrazines 2, 3, and 7
afforded thiosemicarbazides 4, 5, and 6, respectively, in a three- to six-step domino reaction.
EXPERIMENTAL
The solvents were purified and dried in the usual way. The boiling range of the petroleum ether used
was 40–60°C. Thin layer chromatography (TLC): silica gel 60 F254 plastic plates (E. Merck, layer thickness
0.2 mm) detected by UV-absorption. Melting points were measured on a Boetius Rapido PHMK 79/2106
1
(Wägetechnik) instrument. Elemental analyses were carried out with an Erba 1102 instrument. The H and 13C
NMR spectra were recorded at 300 and 75.5 MHz, respectively (DRX 300 Avance Bruker) in CDCl3 solution
with tetramethylsilane as an internal standard.
The starting compound 1 was prepared according to the method described in [12-15].
1-Substituted 4-(2-phenylquinazolin-4-yl) and 4-(2-phenylquinazolin-4-ylidene) thiosemicarbazides
(General Method). To a solution of imidoyl isothiocyanate 1 (1.32 g, 5 mmol) [12-15] in acetone (10 ml) a
hydrazine derivative (5-10 mmol) was added. The reaction mixture was stirred at room temperature (25°C) for
24 h. The solvent was evaporated under reduced pressure and the residue was crystallized from ethanol.
1,1-Dimethyl-4-(2-phenylquinazolin-4-yl) thiosemicarbazide (4). From compound 1 and 1,1-dimethyl-
1
hydrazine (2) (0.4 ml). White crystals (0.89 g, 56%); mp 147-148°C. H NMR spectrum, δ, ppm: 12.98 (1H, s,
N–H···N=C); 8.77 (1H, s, NH); 8.45-8.32 (2H, m, ArH); 8.04-8.01 (1H, m, ArH); 7.9–7.89 (2H, m, ArH);
7.64-7.54 (4H, m, ArH); 2.91 (6H, s, CH3). 13C NMR spectrum, δ, ppm: 178.20 (C=S); 158.79 (C=N, C-2); 155.75
(C=N, C-4); 151.54 (C q); 137.64 (C q); 134.71 (CH Ar); 131.24 (CH Ar); 129.83 (CH Ar); 129.01 (CH Ar);
128.29 (CH Ar); 127.96 (CH Ar); 120.74 (CH Ar); 112.57 (C q); 47.41 (CH3). Found, %: C 63.08; H 5.26;
N 21.61; S 9.88. C17H17N5S. Calculated, %: C 63.13; H 5.30; N 21.65; S 9.91.
1,1-Diphenyl-4-(2-phenylquinazolin-4(3H)-ylidene) thiosemicarbazide (5). From compound 1 and
1
1,1-diphenylhydrazine 4 (0.7 ml). White crystals (1.4 g, 64 %); mp 166-167°C. H NMR spectrum, δ, ppm (J,
13
Hz): 16.75 (1H, s, N–H···S=C); 8.32 (2H, d, J = 7.9, ArH); 7.82-7.32 (18H, m, ArH, NH). C NMR spectrum,
δ, ppm: 188.32 (N–H···S=C); 155.85 (C=N, C-2); 149.34 (C=N, C-4); 148.54 (C q); 134.90 (CH Ar); 132.67 (C q);
132.08 (CH Ar); 129.35 (CH Ar); 129.22 (CH Ar); 128.15 (CH Ar); 127.61 (CH Ar); 127.53 (CH Ar); 126.11
(CH Ar); 121.43 (C q). Found: C 72.31; H 4.65; N 15.64; S 7.08. C27H21N5S. Calculated, %: C 72.46; H 4.73;
N 15.65; S 7.16.
4-(2-Phenylquinazolin-4(3H)-ylidene)-2-(propen-2-yl)-1-(propan-2-ylidene) thiosemicarbazide (6).
From compound 1 and hydrazine hydrate (85%, 0.5 ml, 10 mmol). Yellow powder (0.63 g, 34 %), mp
1
162-163°C. H NMR spectrum, δ, ppm: 16.72 (1H, s, N–H···S=C); 8.36-8.24 (3H, m, ArH); 7.78-7.64 (2H, m,
ArH); 7.49-7.31 (4H, m, ArH); 2.89 (2H, s, CH2); 2.13 (3H, s, CH3); 1.80 (6H, s, 2CH3). 13C NMR spectrum, δ,
ppm: 181.91 (N–H···S=C); 155.56 (C=N, C-2); 149.98 (C=N, C-4); 149.40 (C q); 134.61 (CH Ar); 132.76 (C q);
131.97 (CH Ar); 129.32 (CH Ar); 128.60 (CH Ar); 127.67 (CH Ar); 127.30 (CH Ar); 125.41 (CH Ar); 121.73
(C q); 67.45 (C=CH2); 55.52 (C=CH2); 27.96 (2CH3); 17.05 (CH3). Found, %: C 66.95; H 5.51; N 18.43; S 8.48.
C21H21N5S. Calculated, %: C 67.17; H 5.64; N 18.65; S 8.54.
1377